enzastaurin has been researched along with cytochrome c-t in 2 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jane, EP; Pollack, IF | 1 |
| Frank, B; Lemke, D; Maurer, G; Rieger, J; Tabatabai, G; Weiler, M; Weller, M; Wick, W | 1 |
2 other study(ies) available for enzastaurin and cytochrome c-t
| Article | Year |
|---|---|
The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cells.
Topics: Apoptosis; Benzoquinones; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Down-Regulation; Drug Synergism; Glioma; HSP90 Heat-Shock Proteins; Humans; Indoles; Lactams, Macrocyclic; Oncogene Protein v-akt; Phosphorylation | 2008 |
Enzastaurin-induced apoptosis in glioma cells is caspase-dependent and inhibited by BCL-XL.
Topics: Adult; Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; bcl-X Protein; Brain Neoplasms; Caspases; Cell Line, Tumor; Cytochromes c; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glioma; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Indoles; Mitochondria; Protein Kinase C; Proto-Oncogene Proteins c-akt; Receptors, TNF-Related Apoptosis-Inducing Ligand | 2008 |